The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist

por Li, Xaria X., Kumar, Vinod, Clark, Richard J., Lee, John D., Woodruff, Trent M.
Publicado 2021

TLQP-21 is a low potency partial C3aR activator on human primary macrophages

por Li, Xaria X., Lee, John D., Lee, Han S., Clark, Richard J., Woodruff, Trent M.
Publicado 2023

Optimisation of a Microfluidic Method for the Delivery of a Small Peptide

por Han, Felicity Y., Xu, Weizhi, Kumar, Vinod, Cui, Cedric S., Li, Xaria, Jiang, Xingyu, Woodruff, Trent M., Whittaker, Andrew K., Smith, Maree T.
Publicado 2021

Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors

por Pandey, Shubhi, Kumari, Punita, Baidya, Mithu, Kise, Ryoji, Cao, Yubo, Dwivedi-Agnihotri, Hemlata, Banerjee, Ramanuj, Li, Xaria X., Cui, Cedric S., Lee, John D., Kawakami, Kouki, Maharana, Jagannath, Ranjan, Ashutosh, Chaturvedi, Madhu, Jhingan, Gagan Deep, Laporte, Stéphane A., Woodruff, Trent M., Inoue, Asuka, Shukla, Arun K.
Publicado 2021

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

por Albornoz, Eduardo A., Amarilla, Alberto A., Modhiran, Naphak, Parker, Sandra, Li, Xaria X., Wijesundara, Danushka K., Aguado, Julio, Zamora, Adriana Pliego, McMillan, Christopher L. D., Liang, Benjamin, Peng, Nias Y. G., Sng, Julian D. J., Saima, Fatema Tuj, Fung, Jenny N., Lee, John D., Paramitha, Devina, Parry, Rhys, Avumegah, Michael S., Isaacs, Ariel, Lo, Martin W., Miranda-Chacon, Zaray, Bradshaw, Daniella, Salinas-Rebolledo, Constanza, Rajapakse, Niwanthi W., Wolvetang, Ernst J., Munro, Trent P., Rojas-Fernandez, Alejandro, Young, Paul R., Stacey, Katryn J., Khromykh, Alexander A., Chappell, Keith J., Watterson, Daniel, Woodruff, Trent M.
Publicado 2022